Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells
- 3 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 331 (2) , 621-629
- https://doi.org/10.1016/j.bbrc.2005.03.212
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 42 references indexed in Scilit:
- Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry siteBiochemical and Biophysical Research Communications, 2005
- Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1Journal of Virology, 2004
- Interference of hepatitis A virus replication by small interfering RNAsBiochemical and Biophysical Research Communications, 2004
- Immunization and the Decline of Viral Hepatitis As A Cause of Acute Liver FailureHepatology, 2003
- Amantadine and Rimantadine Have No Direct Inhibitory Effects against Hepatitis C Viral Protease, Helicase, ATPase, Polymerase, and Internal Ribosomal Entry Site–Mediated TranslationThe Journal of Infectious Diseases, 2000
- PKR; a sentinel kinase for cellular stressOncogene, 1999
- Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis CNew England Journal of Medicine, 1998
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Effect of antiviral substances on hepatitis A virus replication in vitroJournal of Medical Virology, 1987
- Recombinant α2c-interferon therapy in fulminant viral hepatitisJournal of Hepatology, 1987